[{"Assets_0_FY_USD":40100000.0,"CommonStockSharesOutstanding_0_FY_shares":38649237.0,"EarningsPerShareBasic_4_FY_USD":-0.76,"EarningsPerShareDiluted_4_FY_USD":-0.76,"NetIncomeLoss_4_FY_USD":-29400000.0,"StockholdersEquity_0_FY_USD":18700000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":38644395.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":38644395.0,"Ticker":"VXRT","CIK":"72444","name":"AVIRAGEN THERAPEUTICS, INC.","OfficialName":"Vaxart Inc Common Stock","form":"10-K","period":"20170630","fy":"2017.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"564888665.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20170901"}]